Skip to main content
SpringerLink
Log in

Inappropriate corticosteroid use in COPD not beneficial and costly

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Fens T, et al. The Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With COPD: ISPOR's Guidance on Budget Impact in Practice. Value in Health : 16 Aug 2019. Available from: URL: https://doi.org/10.1016/j.jval.2019.05.006

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inappropriate corticosteroid use in COPD not beneficial and costly. PharmacoEcon Outcomes News 835, 19 (2019). https://doi.org/10.1007/s40274-019-6156-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6156-3

Search

Navigation